Long-term Study to Evaluate Different Dental Implant Alloys in Straumann 3.3mm Diameter Bone Level Implants
Long-term, Prospective, Cohort Study to Evaluate Safety and Efficacy of Two Different Dental Implant Alloys in Straumann 3.3mm Diameter Bone Level Implants for Removable Prosthesis in Patients With Edentulous Mandibles
1 other identifier
observational
49
1 country
1
Brief Summary
Patients with an edentulous mandible restored with implants who have participated in the core study CR 04/07 will be recruited for this extension study. No further interventions will be made for this extension study other than a clinical follow-up examination and questionnaires. Patients will not receive an investigational treatment in this study. Patients will be followed at 5 to 10 years from the date of the original implant loading
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2013
CompletedStudy Start
First participant enrolled
June 1, 2013
CompletedFirst Posted
Study publicly available on registry
June 14, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedJanuary 7, 2020
January 1, 2020
5.3 years
April 29, 2013
January 6, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Implant Survival
This is a long term follow up extension study including evaluations at 5 and 10 years after the implant procedure from the core study. Implant survival will be assessed based on surviving implants for all patients at 10 years.
10 years following implant procedure date
Secondary Outcomes (1)
Crestal bone level change
5 and 10 years
Study Arms (2)
Roxolid
Patient do not receive an intervention in the extension study. Rather they are followed on the implant treatment from the core study which included a split-mouth design where all patients received both a Roxolid and SLActive implant.
SLActive
Patient do not receive an intervention in the extension study. Rather they are followed on the implant treatment from the core study which included a split-mouth design where all patients received both a Roxolid and SLActive implant.
Eligibility Criteria
Male or female patient ≥ 18 years of age who were provided with an implant supported over-denture in the mandible in the course of the core study (CR 04/07).
You may qualify if:
- Subjects must have voluntarily signed the informed consent form
- Patients must be committed to participate in the study until the ten year follow-up examinations
- Subjects must have received treatment in the CR 04/07 core study
- Subjects must have completed 3 year visit of core study
You may not qualify if:
- Physical handicaps that would interfere with the ability to perform adequate oral hygiene or attend follow up visits
- Use of any investigational drug or device during the study
- Conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance, unreliability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Frauke Müller
Geneva, 1211, Switzerland
Related Publications (2)
Muller F, Al-Nawas B, Storelli S, Quirynen M, Hicklin S, Castro-Laza J, Bassetti M, Srinivasan M; Roxolid Study Group. Small-diameter titanium grade IV and titanium-zirconium implants in edentulous mandibles: Ten-year results from a double-blind, randomised controlled split-mouth core-trial. Clin Oral Implants Res. 2024 Jan;35(1):77-88. doi: 10.1111/clr.14199. Epub 2023 Nov 9.
PMID: 37942666DERIVEDMuller F, Al-Nawas B, Storelli S, Quirynen M, Hicklin S, Castro-Laza J, Bassetti R, Schimmel M; Roxolid Study Group. Small-diameter titanium grade IV and titanium-zirconium implants in edentulous mandibles: five-year results from a double-blind, randomized controlled trial. BMC Oral Health. 2015 Oct 12;15(1):123. doi: 10.1186/s12903-015-0107-6.
PMID: 26458813DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Frauke Müller, Prof.
University of Geneva
- PRINCIPAL INVESTIGATOR
Bilal Al-Nawas, Prof.
Klinikum der Johannes - Gutenberg - Universität Mainz
- PRINCIPAL INVESTIGATOR
Eugenio Romeo, Prof.
Università degli Studi di Milano, Dipartimento di Medicina, Chirurgia e Odontoiatria
- PRINCIPAL INVESTIGATOR
Joke Duyck, Prof.
Department of Oral Health Sciences, Catholic University (KU) Leuven
- PRINCIPAL INVESTIGATOR
Torsten E Reichert, Prof.
Klinikum der Universität Regensburg
- PRINCIPAL INVESTIGATOR
Alessandro Perucchi, Prof.
Luzerner Kantonsspital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2013
First Posted
June 14, 2013
Study Start
June 1, 2013
Primary Completion
September 1, 2018
Study Completion
September 1, 2018
Last Updated
January 7, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share